Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2021
Mar. 31, 2021
Current assets    
Cash $ 23,224,925 $ 9,861,575
Accounts receivable 131,966 149,082
Prepaid expenses and other current assets 212,308 341,081
Total current assets 23,569,199 10,351,738
Property and equipment, net 213,625 160,976
Right-of-use lease asset 0 40,363
Patents, net 2,476 56,954
Restricted cash 46,726 46,726
Deposits 42,159 12,159
Total assets 23,874,185 10,668,916
Current liabilities    
Accounts payable 254,176 337,678
Due to related parties 134,207 118,520
Deferred revenue 114,849 114,849
Lease liability, current portion 0 42,543
Other current liabilities 471,117 761,636
Total current liabilities 974,349 1,375,226
Commitments and Contingencies (Note 12)
Stockholders’ Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized; 15,397,299 and 12,150,597 shares issued and outstanding as of September 30, 2021 and March 31, 2021, respectively 15,399 12,152
Additional paid-in capital 147,041,683 129,331,542
Accumulated deficit (124,018,372) (119,913,090)
Total Aethlon Medical, Inc. stockholders’ equity before noncontrolling interests 23,038,710 9,430,604
Noncontrolling interests (138,874) (136,914)
Total stockholders’ equity 22,899,836 9,293,690
Total liabilities and stockholders’ equity $ 23,874,185 $ 10,668,916